ImageneBio (IMA) Other Accumulated Expenses (2020 - 2025)

ImageneBio has disclosed Other Accumulated Expenses across 6 years of filings, most recently posting $164000.0 for Q4 2025.

• Other Accumulated Expenses for Q4 2025 came in at $164000.0, up 70.83% year-over-year; the trailing twelve-month figure through Dec 2025 was $164000.0 (up 70.83% YoY), and the FY2025 annual result was $164000.0, up 70.83% from the prior year.
• Other Accumulated Expenses came in at $164000.0 for Q4 2025 at ImageneBio, down from $3.5 million in the prior quarter.
• In the past five years, Other Accumulated Expenses ranged from a high of $6.1 million in Q3 2023 to a low of $11000.0 in Q2 2021.
• The 5-year median for Other Accumulated Expenses is $203500.0 (2022), against an average of $1.4 million.
• Peak annual rise in Other Accumulated Expenses reached 40723.08% in 2022, while the deepest fall reached 98.8% in 2022.
• ImageneBio's Other Accumulated Expenses stood at $2.5 million in 2021, then plunged by 95.22% to $119000.0 in 2022, then declined by 28.57% to $85000.0 in 2023, then advanced by 12.94% to $96000.0 in 2024, then surged by 70.83% to $164000.0 in 2025.
• The last three Other Accumulated Expenses figures came in at $164000.0 (Q4 2025), $3.5 million (Q3 2025), and $1.1 million (Q2 2025), per Business Quant data.